VisiFlora is a 21-ingredient "gut-eye axis" capsule ($69/$59/$49, 60-day guarantee with all-bottles-returned fine print) that names the AREDS2 core — lutein, zeaxanthin, vitamins C and E, zinc — plus astaxanthin, saffron, bilberry, quercetin, rutin, grape seed, ALA and more, across four proprietary blends disclosing exactly one amount: zinc at 11 mg, where AREDS2 used 80. That 14% figure is the label's most informative fact — quantified proof of the fractional-dose borrower pattern our eyes page describes. Evidence rating: 2.0/5. Product Fit Score: 3.2/5. Anyone with diagnosed intermediate AMD needs a faithful AREDS2 formula (every dose printed, eye-doctor supervised); everyone else needs the dilated exam that finds out.
VisiFlora
- Form
- capsule
- Price
- $69 (1 bottle) · $59/bottle (3) · $49/bottle (6)
- Guarantee
- 60-day money-back (stated by seller)
- Sold via
- clickbank
- Label amounts
- Label web-sourced; 21 named ingredients across 4 proprietary blends with exactly ONE amount disclosed (zinc 11 mg — 14% of the AREDS2 dose), per a policy-verification source; guarantee 60 days dominant (one reviewer claims 90), all-bottles-returned + buyer-paid shipping per refund policy
✓ 60-day refund window stated by seller — long enough to run an honest self-trial
Check current price on the seller's site
Affiliate link. Prices and guarantee as shown on the seller's page on 3 September 2026; they may have changed. Not independently verified beyond that page.
Evidence & product fit
| Product Fit factor | Score (out of 5) | Why |
|---|---|---|
| Formula completeness | 2.0 | Twenty-one names, four proprietary blends, one amount — a disclosure ratio of 1-in-21 — with refund fine print (all bottles returned, buyer-paid shipping) confirmed by a policy-verification source. |
| Ease of use | 4.5 | The capsule format is generally straightforward, but clear serving directions were not available in the product facts we verified. |
| Guarantee & buying terms | 3.5 | 60 days dominant (a stray 90 circulates), mechanics confirmed — with the return-shipping condition worth knowing. |
| Price / value | 2.0 | $49–69/bottle when a faithful AREDS2 product costs less and prints every number. |
| Category relevance | 4.0 | The named formula is broadly aligned with eye and vision support positioning. Category relevance measures fit to the intended use; it does not mean the finished product has been clinically proven effective. |
Might suit you if…
- The screen-strain wellness buyer who understands they're purchasing a broad low-dose antioxidant blend, not the AREDS2 evidence — and who'd still be better served dose-wise by leafy greens and the 20-20-20 rule
Skip it if…
- Anyone with diagnosed AMD — the evidence belongs to faithful AREDS2 formulations at printed doses under eye-care supervision; an 11 mg-zinc blend is not that product
- Anyone buying for floaters, cataracts, or "vision restoration" — our eye pages cover why no capsule addresses any of them
- Anyone who won't use the guarantee's actual mechanics — refunds require returning all bottles at your shipping cost
The Evidence Rating reflects research on the finished product and/or named ingredients for the intended use. The Product Fit Score is a separate practical assessment of formula completeness, ease of use, guarantee/buying terms, price/value and category relevance. Neither score is a customer rating, and affiliate relationships do not determine either score. See the full scoring method.
What VisiFlora is
VisiFlora is a once-daily "22-in-1" eye capsule sold through BuyGoods at $69/$59/$49 with a 60-day guarantee (fine print: all bottles returned, shipping on you), built on a four-blend, 21-ingredient roster — the AREDS2 names plus astaxanthin, saffron, bilberry, the "Gut Armor" trio (quercetin, rutin, grape seed), ALA, taurine, eyebright and friends — and exactly one disclosed amount: zinc, 11 mg.
The fidelity test, self-administered
Our eyes category page grades this aisle on one question: fidelity to AREDS2 — C 500 mg, E 400 IU, zinc 80 mg, copper 2 mg, lutein 10 mg, zeaxanthin 2 mg, proven only in diagnosed intermediate AMD. VisiFlora takes the test in its own handwriting: the one number it prints is 14% of the trial dose, and twenty ingredients share whatever capsule space remains. Everything else follows the borrower-tier pattern: trial-grade names, wellness-grade amounts, plus a genuinely interesting research area (gut-eye axis) hired as a slogan.
| The ledger | |
|---|---|
| AREDS2 names present | Yes — evidence stays with AREDS2 doses |
| Disclosed amounts | 1 of 21 — and it's fractional |
| Product trial | None |
| 60-day guarantee | Real; all-bottles + buyer-paid return shipping |
| Gut-eye claim | Emerging science, decorative use |
Verdict
2.4/5 — better-named than most of its aisle, convicted by its own arithmetic. The two purchases that outperform it: for the diagnosed, a faithful AREDS2 formula with printed doses and an ophthalmologist's blessing; for everyone else, the dilated exam — the intervention on every eye page here that actually finds and saves vision.
Frequently asked questions
Why does the zinc number matter so much?
Because it's the only window into the label. AREDS2 — the one genuinely proven eye formula, for diagnosed intermediate AMD — used zinc 80 mg (with copper 2 mg); VisiFlora's sole disclosed amount is 11 mg, 14% of that. When a 21-ingredient blend reveals one dose and it's fractional, the base-rate assumption for the twenty hidden ones writes itself. Our do-eye-vitamins page calls this the borrower tier; VisiFlora is the rare product that quantifies its own membership.
Is the gut-eye axis real?
It's real emerging science — gut-barrier integrity, LPS translocation and retinal inflammation are active research topics — and it's doing marketing work here that the formula can't cash. No trial shows any oral blend improving vision through that pathway, and "supports the gut-eye connection" is unfalsifiable as labeled. Interesting biology, decorative claim.
What should different readers actually do?
Diagnosed intermediate AMD — a faithful AREDS2 product with every dose printed, chosen with your ophthalmologist (the only scenario with trial-backed benefit). Screen fatigue — the 20-20-20 rule, blink breaks and an updated prescription outperform capsules. New floaters or flashes — same-day eye care, per the floaters page. Everyone over 60 — the dilated exam, which finds the treatable before it costs vision.
When the one disclosed number convicts the product, what does that teach about disclosure?
That partial transparency is a marketing calculation, not a virtue — brands disclose what survives scrutiny and hide what doesn't, so a lone printed number invites the question 'why this one?' Here the disclosed figure sits far below the AREDS2 doses that define this category's only real evidence, which means the label's single act of honesty documents its own inadequacy — and the undisclosed remainder earns no benefit of the doubt. The buyer's heuristic: judge a label by its least flattering disclosed fact, and assume hidden values are worse, because a company holding better numbers would print them. Selective disclosure is disclosure of the selection process.
VisiFlora — from $69 · 60-day seller refund window
Check current price on the seller's site Compare eye health supplements
Affiliate links. Our evaluation is unaffected — the criterion scores above explain the verdict either way.
References
- National Eye Institute. Age-Related Macular Degeneration (AMD) (2024). https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration
- JAMA. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial (2013). PubMed PMID 23644932. https://pubmed.ncbi.nlm.nih.gov/23644932/
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
Eye supplements do not restore lost vision or treat most eye diseases. Evidence is condition-specific—for example, the AREDS2 formula applies to selected people with age-related macular degeneration, not general vision improvement. Sudden vision loss, flashes with a curtain-like shadow, severe eye pain or new neurologic symptoms require urgent care.